These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8163868)

  • 1. [Activation and signal transduction of the erythropoietin receptor].
    Yoshimura A
    Seikagaku; 1994 Feb; 66(2):154-8. PubMed ID: 8163868
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and its receptor: signaling and clinical manifestations.
    Cohen J; Supino-Rosin L; Barzilay E; Eisen-Lev R; Mittelman M; Neumann D
    Isr Med Assoc J; 2002 Nov; 4(11):1072-6. PubMed ID: 12489509
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality control of receptor-kinase signaling complexes.
    Bonifacino JS
    Dev Cell; 2002 Jan; 2(1):1-2. PubMed ID: 11782306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turning cells red: signal transduction mediated by erythropoietin.
    Richmond TD; Chohan M; Barber DL
    Trends Cell Biol; 2005 Mar; 15(3):146-55. PubMed ID: 15752978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury.
    Campana WM; Myers RR
    FASEB J; 2001 Aug; 15(10):1804-6. PubMed ID: 11481236
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin receptor signal transduction requires protein geranylgeranylation.
    Hamadmad SN; Henry MK; Hohl RJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):403-9. PubMed ID: 16203826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif.
    Constantinescu SN; Huang LJ; Nam H; Lodish HF
    Mol Cell; 2001 Feb; 7(2):377-85. PubMed ID: 11239466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin receptor activation by a ligand-induced conformation change.
    Remy I; Wilson IA; Michnick SW
    Science; 1999 Feb; 283(5404):990-3. PubMed ID: 9974393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT1 is involved in signal transduction in the EPO induced HEL cells.
    Chu J; Gui CY; Fan J; Tang XD; Qiao RL
    Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
    Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
    Sola A; Rogido M; Lee BH; Genetta T; Wen TC
    Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
    Fan H; Kanji S; Zhai M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo.
    Cull V; Tilbrook PA; Adenan AS; Chappell D; Ingley E; Sarna MK; Palmer TN; Watowich SS; Klinken SP
    Oncogene; 2000 Feb; 19(7):953-60. PubMed ID: 10702804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
    Machide M; Mano H; Todokoro K
    Oncogene; 1995 Aug; 11(4):619-25. PubMed ID: 7651724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
    Yamamura Y; Senda H; Noda M; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.
    Digicaylioglu M; Lipton SA
    Nature; 2001 Aug; 412(6847):641-7. PubMed ID: 11493922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells.
    Tilbrook PA; Bittorf T; Callus BA; Busfield SJ; Ingley E; Klinken SP
    Cell Growth Differ; 1996 Apr; 7(4):511-20. PubMed ID: 9052992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escape from death.
    Nath D
    Nat Rev Mol Cell Biol; 2001 Sep; 2(9):644. PubMed ID: 11575276
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of mitogen-activated protein kinase cascade through erythropoietin receptor.
    Todokoro K; Sugiyama M; Nishida E; Nakaya K
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1912-9. PubMed ID: 7524495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.